Wealth Enhancement Advisory Services
BLFS icon

Wealth Enhancement Advisory Services’s BioLife Solutions BLFS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5K Buy
16,162
+503
+3% +$11.8K ﹤0.01% 3968
2026
Q1 		$15.9K Buy
15,659
+14,822
+1,771% +$328K ﹤0.01% 3519
2025
Q4 		$37.5K Sell
837
-71
-8% -$1.86K ﹤0.01% 3545
2025
Q3 		$23.9K Buy
+908
New +$21.5K ﹤0.01% 3493

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wealth Enhancement Advisory Services's BLFS Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its BioLife Solutions (BLFS) stake by 3.2% in Q2 2026, buying an estimated $11.8K and bringing the position to 16,162 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3968.

Wealth Enhancement Advisory Services first reported a position in BLFS in Q3 2025 and has held it in 4 quarters since. The position peaked at $37.5K in Q4 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Wealth Enhancement Advisory Services held 16,162 shares of BioLife Solutions worth $35.5K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 503 BioLife Solutions shares in Q2 2026, an estimated $11.8K.
  • BioLife Solutions made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3968 holding.
  • Wealth Enhancement Advisory Services first reported a position in BioLife Solutions in Q3 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's BioLife Solutions position peaked at $37.5K in Q4 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.